Department of Cardiology, St Antonius Ziekenhuis, Nieuwegein, The Netherlands.
Department of Cardiology, University of Verona, Verona, Italy.
Catheter Cardiovasc Interv. 2018 Nov 1;92(5):E299-E307. doi: 10.1002/ccd.27539. Epub 2018 Feb 7.
Coronary chronic total occlusions (CTO) usually coexist with diffusely diseased coronary segments proximal and/or distal to the CTO segment. During percutaneous treatment of CTO, multiple overlapping stents are often needed to treat these long lesions.
Aim of this study is to report the first use of long, tapered coronary sirolimus-eluting stents (SES) in this setting.
This is a retrospective analysis of 100 consecutive patients undergoing CTO recanalization following the hybrid algorithm. Procedural success rate was 89% (11 failures). Among the successful cases, "conventional" drug-eluting stents(DES) were used in 40(44.9%) patients, while in 49(55%) patients long-tapered SES were attempted with a success rate of 98% (1 cross-over to regular stents). Total stent length in the long-tapered DES group was higher compared to the "conventional" stenting group (76 ± 28 mm vs 46 ± 22 mm, P < .001), with a similar total number of stent (1.6 ± 0.8 vs 1.9 ± 0.8). At quantitative coronary analysis, proximal and distal segment involvement was more extended in patients undergoing long-tapered stenting, with longer overall lesion length. No differences in periprocedural complications and clinical outcomes at a mean follow-up of 303 ± 179 days were observed.
The use of long tapered coronary DES is technically feasible and safe for the percutaneous treatment of CTOs, especially for patients presenting with long lesions.
冠状动脉慢性完全闭塞(CTO)通常与 CTO 段近端和/或远端弥漫性病变的冠状动脉节段共存。在 CTO 的经皮治疗中,通常需要多个重叠支架来治疗这些长病变。
本研究旨在报告在这种情况下首次使用长锥形冠状动脉西罗莫司洗脱支架(SES)。
这是对 100 例连续接受杂交算法 CTO 再通治疗的患者进行的回顾性分析。手术成功率为 89%(11 例失败)。在成功的病例中,40 例(44.9%)患者使用“常规”药物洗脱支架(DES),49 例(55%)患者尝试使用长锥形 SES,成功率为 98%(1 例交叉至常规支架)。长锥形 DES 组的总支架长度明显长于“常规”支架组(76±28mm 比 46±22mm,P<.001),总支架数量相似(1.6±0.8 比 1.9±0.8)。在定量冠状动脉分析中,长锥形支架置入患者的近段和远段节段受累更为广泛,总病变长度更长。在平均 303±179 天的随访中,未观察到围手术期并发症和临床结果的差异。
长锥形冠状动脉 DES 的使用在技术上是可行的,对于 CTO 的经皮治疗是安全的,特别是对于存在长病变的患者。